Silver vanadium oxide provided with a metal oxide coating
First Claim
Patent Images
1. An electrochemical cell, which comprises:
- a) an anode of an alkali metal;
b) a cathode of a composite cathode active material comprising a core of a first cathode active material provided with a coating of a second cathode active material, wherein the first cathode active material is not the second cathode active material; and
c) an electrolyte activating the anode and the cathode.
4 Assignments
0 Petitions
Accused Products
Abstract
An improved cathode material for nonaqueous electrolyte lithium electrochemical cell is described. The preferred active material is ε-phase silver vanadium oxide (Ag2V4O11) coated with a protective layer of a metal oxide, preferably γ-phase SVO (Ag1.2V3O1.8). The SVO core provides high capacity and rate capability while the protective coating reduces reactivity of the active particles with electrolyte to improve the long-term stability of the cathode.
-
Citations
25 Claims
-
1. An electrochemical cell, which comprises:
-
a) an anode of an alkali metal;
b) a cathode of a composite cathode active material comprising a core of a first cathode active material provided with a coating of a second cathode active material, wherein the first cathode active material is not the second cathode active material; and
c) an electrolyte activating the anode and the cathode. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
-
-
11. An implantable medical device, which comprises:
-
a) a device housing;
b) control circuitry contained inside the device housing;
c) an electrochemical cell housed inside the device housing for powering the control circuitry, the cell comprising;
i) an anode comprising lithium;
ii) a cathode of a composite cathode active material comprising a core of a first cathode active material provided with a coating of a second cathode active material, wherein the first cathode active material is not the second cathode active material; and
d) a nonaqueous electrolyte activating the anode and the cathode; and
e) a lead connecting the device housing to a body part intended to be assisted by the medical device, wherein the electrochemical cell powers the control circuitry both during a device monitoring mode to monitor the physiology of the body part and a device activation mode to provide the therapy to the body part. - View Dependent Claims (12, 13, 14, 15, 16)
-
-
17. A method for providing a composite cathode active material, comprising the steps of:
-
a) providing a core cathode active material selected from the group consisting of ε
-phase SVO, β
-phase SVO, γ
-phase SVO, CSVO, V2O5, MnO2, LiCoO2, LiNiO2, LiMnO2, LiMn2O4, CuO2, TiS2, Cu2S, FeS, FeS2, Ag2O, Ag2O2, CuF, Ag2CrO4, copper vanadium oxide, and mixtures thereof is granular form;
b) providing a solution of an organic solvent having a coating metal selected from ε
-phase SVO, β
-phase SVO, γ
-phase SVO, CSVO, V2O5, MnO2, LiCoO2, LiNiO2, LiMnO2, LiMn2O4, CuO2, TiS2, Cu2S, FeS, FeS2, Ag2O, Ag2O2, CuF, Ag2CrO4, copper vanadium oxide, and mixtures thereof provided therein, wherein the core cathode active material is not the coating cathode active material;
c) mixing the first core cathode active material into the sol-gel solution containing the second coating cathode active material to thereby form a gel of the second cathode active material coating the core cathode active material;
d) drying the resulting coated cathode active material to substantially remove the solvent material; and
e) heating the dried coated core cathode active material to provide the composite cathode active material. - View Dependent Claims (18, 19, 20, 21, 22, 23, 24, 25)
-
Specification